Title: Risk/benefit analysis for the use and approval of thrombolytic, antiarrhythmic, and hypolipidemic agents
Subjects: Anti-Arrhythmia Agents, Antilipemic agents, Congresses, Effectiveness, Fibrinolytic agents, Myocardial depressants, Risk assessment, Therapeutic use, Cardiovascular agents, Hypolipidemic Agents, Risk Factors